[HTML][HTML] Olfactory training in post-COVID-19 persistent olfactory disorders: value normalization for threshold but not identification
C Vandersteen, M Payne, LÉ Dumas… - Journal of Clinical …, 2022 - mdpi.com
(1) Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.
C Vandersteen, M Payne, LÉ Dumas… - Journal of Clinical …, 2022 - search.ebscohost.com
Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification
C Vandersteen, M Payne, LÉ Dumas… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
(1) Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.
C Vandersteen, M Payne, LÉ Dumas… - Journal of Clinical …, 2022 - europepmc.org
Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification
C Vandersteen, M Payne, LÉ Dumas… - Journal of Clinical …, 2022 - search.proquest.com
Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
[HTML][HTML] Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification
C Vandersteen, M Payne, LÉ Dumas… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.
C Vandersteen, M Payne, LÉ Dumas… - Journal of Clinical …, 2022 - europepmc.org
Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …
patients one year after COVID-19 infection. No treatment is, to date, significantly effective on …